This federal contract award, valued at $25,995.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of September 10, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, was awarded this delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,630.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of September 12, 2024. This appears to be a Firm Fixed Price delivery order contract, and there is no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award, valued at $33,351.93, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of July 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,430.48 firm fixed-price delivery order is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of August 6, 2024 and does not utilize a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts and indefinite...
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, with Amerisourcebergen Drug Corp's Corporate Office Division. The $43,451.24 firm fixed-price contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 21, 2024, and was awarded on August 20, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal...
This federal contract award, valued at $10,333.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024 and was awarded on August 2, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military...
This federal contract award, valued at $22,715.24, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of October 16, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program. As one of the largest pharmaceutical distributors in the United...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $22,812.21 contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of September 6, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products...
This federal contract award, valued at $11,835.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a prescription medication. This is a Firm Fixed Price Delivery Order contract with a completion date of September 9, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, has a significant presence...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $5,260.00, is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the specified medication to support...